Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
The Oncologist|August 23, 2024
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational studyFrancesco Schettini, Marianna Sirico, Marco Loddo, et al.Journal of Cancer Research and Clinical Oncology|November 5, 2015
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective studyGrazia Arpino, Andrea Michelotti, Mauro Truini, et al.Cancer Immunology, Immunotherapy : CII|January 10, 2023
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based studyJavier García-Corbacho, Alberto Indacochea, Azucena E González Navarro, et al.Breast (Edinburgh, Scotland)|August 23, 2025
Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectivesLeonor Matos, Mette van Ramshorst, Volkmar Müller, et al.Breast (Edinburgh, Scotland)|February 7, 2020
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological modelLuisa Carbognin, Michele Simbolo, Anna Caliò, et al.JNCI Cancer Spectrum|August 12, 2025
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysisFrancesco Schettini, Sabrina Nucera, Giuseppe Di Grazia, et al.Journal of the National Cancer Institute|May 15, 2020
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Fabiola Giudici, Mario Giuliano, et al.Oncology|December 7, 2021
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?Alessandra Fabi, Mariangela Ciccarese, Sinome Scagnoli, et al.Cancer Treatment Reviews|December 22, 2024
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysisFrancesco Schettini, Sabrina Nucera, Tomás Pascual, et al.Molecular Oncology|May 29, 2021
Gene expression profiles of breast cancer metastasis according to organ siteFara Brasó-Maristany, Laia Paré, Nuria Chic, et al.Pageof 9